NYSE$PRGO

Perrigo Company · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Perrigo's Q4 2023 net sales increased slightly, with adjusted EPS up 14.7%.

Perrigo's Q4 2023 results showed a slight increase in net sales and a significant improvement in adjusted earnings per share. Net sales from continuing operations were a fourth quarter record. The company launched 'Project Energize' to drive sustainable growth.

  • Net sales increased 0.1% compared to the prior year quarter.
  • Consumer Self-Care International (CSCI) net sales increased 5.9% compared to the prior year quarter.
  • Adjusted diluted earnings per share (EPS) was $0.86, compared to $0.75 in the prior year quarter, an increase of 14.7%.
  • Fourth quarter operating cash flow was $209 million.

Headline financials

Total Revenue

$1.16B

Previous: $1.16B+0.2%
EPS (adj)

$0.86

Previous: $0.75+14.7%
Adjusted Operating Income

$167M

Previous: $156M+7.1%
Reported Operating Margin

-1.3%

Previous: 33.1%-103.9%
Adjusted Gross Margin

39.8%

Previous: 38.4%+3.6%
Capital Expenditures

-$26.7M

Previous: $26.4M-201.1%
Net Income

-$28M

Previous: -$13M-115.4%
Operating Income

$91M

Previous: $31M+193.5%
Gross Profit

$427M

Previous: $383M+11.7%
R&D Expense

$29.7M

No prior period
Stock-Based Comp

$10.6M

Previous: $8.2M+29.3%

Revenue & EPS history

Perrigo · Revenue · Quarterly

$1.16B

Q4 2023+0.2%vs Q4 2022
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Revenue by segment

Perrigo · $1.12B total across 2 segments · Q3 2023

  • Consumer Self-Care Americas
    $704M-2.5%
  • Consumer Self-Care International
    $420M+11.2%

Forward guidance

The Company's fiscal year 2024 outlook includes organic net sales growth of 1.0% to 3.0% compared to the prior year and adjusted diluted EPS range of between $2.50 to $2.65.

Tailwinds

  • Organic net sales growth of 1.0% to 3.0% compared to the prior year
  • Reported net sales flat compared to the prior year
  • Adjusted diluted EPS range of between $2.50 to $2.65
  • Mid-teens adj. EPS growth, excluding U.S. infant formula from both years
  • Operating cash flow conversion (operating cash flow as a percentage of adjusted net income) of approximately 90% - 100%

Headwinds

  • Actions the Company is taking to augment and strengthen its infant formula business leads to adjusted diluted EPS relatively in-line with the prior year.
  • Uncertainty of non-recurring infant formula related charges
  • Timing of restructuring charges
  • General economic conditions
  • Potential adverse changes to U.S. and foreign tax, healthcare and other government policy

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-1.5%

Avg return

Earnings day

-2.1%

Avg return

5 days after

-3.4%

Avg return

30 days after

48%

30 / 63 earnings

Positive

+20.2%

Q4 2024

Best reaction

-25.2%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+5.3%-5.0%-7.0%
Q4 2025-1.5%-21.0%-33.9%
Q3 2025-25.2%-29.4%-33.4%
Q1 2025+7.2%+9.4%+6.0%
Q4 2024+20.2%+22.1%+16.3%
Q3 2024+6.2%+5.4%+10.7%
Q2 2024+1.8%-1.5%+3.3%
Q1 2024-6.9%-8.1%-19.2%
Q4 2023-17.9%-18.2%+0.1%
Q3 2023+2.0%-0.2%+7.3%
Q2 2023+5.8%+7.3%-8.4%
Q1 2023+1.3%-2.2%-6.5%
Q4 2022+3.9%+6.9%-3.2%
Q3 2022-18.3%-14.9%-18.2%
Q2 2022-1.9%-1.7%-9.3%
Q1 2022+9.1%+15.6%+19.7%
Q4 2021+6.4%+4.8%+8.2%
Q3 2021-8.7%-9.8%-23.0%
Q2 2021-16.0%-16.6%-11.1%
Q1 2021+6.1%+6.4%+13.3%
Q4 2020+4.3%+1.7%+0.3%
Q3 2020-0.3%+1.5%+9.9%
Q2 2020-8.5%-6.1%-7.7%
Q1 2020-3.0%-4.4%+0.8%
Q4 2019-16.4%-12.1%-24.0%
Q3 2019-8.1%-9.3%-3.4%
Q2 2019-7.1%-5.4%-1.1%
Q1 2019+7.5%+1.7%-10.1%
Q4 2018+0.8%+4.0%-0.3%
Q3 2018-14.7%-13.0%-20.2%
Q2 2018-10.7%-11.3%-3.3%
Q1 2018-4.9%+0.4%-5.2%
Q4 2017+1.9%-6.0%-5.6%
Q3 2017+8.0%+5.9%+5.4%
Q2 2017+18.3%+17.2%+24.7%
Q1 2017+4.1%+5.0%+8.5%
Q3 2016+6.9%+6.7%-1.2%
Q2 2016-9.8%-7.2%-6.7%
Q1 2016-4.7%
Q4 2015-10.9%
Q3 2015-1.3%
Q2 2015+1.7%
Q1 2015-1.7%
Q4 2014+6.7%
Q3 2014-11.3%
Q2 2014-4.9%
Q1 2014+10.7%
Q4 2013-5.1%
Q3 2013-0.5%
Q2 2013+5.2%
Q1 2013-8.8%
Q4 2012-8.3%
Q3 2012-4.5%
Q1 2012+1.8%
Q2 2012-0.1%
Q4 2011+1.3%
Q3 2011-7.6%
Q2 2011+2.7%
Q1 2011+1.7%
Q4 2010+0.6%
Q3 2010-0.1%
Q2 2010-2.9%
Q1 2010+0.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro